Copyright held by the owner/author(s).

Major Finding: A shared neoantigen vaccine plus immune checkpoint blockade was well-tolerated in advanced solid tumors. Concept: Preliminary clinical activity was observed along with a hierarchy of ...

Genentech’s alectinib (Alecensa) received FDA approval for adjuvant treatment of non–small cell lung cancer (NSCLC) in patients with ALK-positive disease. The decision was based on the phase III ALINA ...

This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license.

1Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, Miami, Florida.

This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license.

The primary treatment for glioblastoma (GBM) is removing the tumor mass as defined by magnetic resonance imaging (MRI). However, MRI has limited diagnostic and predictive value. Tumor-associated ...

The primary treatment for glioblastoma (GBM) is removing the tumor mass as defined by magnetic resonance imaging (MRI). However, MRI has limited diagnostic and predictive value. Tumor-associated ...

MyProstateScore 2.0 (MPS2) proved more accurate at detecting prostate cancer than PSA and other biomarkers, researchers reported, sparing men more invasive testing, such as prostate biopsies and MRI ...

1Cancer Moonshot, White House, Office of Science and Technology Policy, Washington, District of Columbia. Search for other works by this author on: 1Cancer Moonshot, White House, Office of Science and ...

2Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands. *Corresponding Author: Ferenc A. Scheeren, Department of Dermatology, Leiden University Medical Center, ...

1Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom. 2Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer ...